Court Lifts Block on MSN’s Entresto Copy as Another Rejects Ban

The Federal Circuit won’t block the launch of MSN Pharmaceuticals Inc.'s copy of the lucrative heart-failure drug Entresto while Novartis Pharmaceuticals Corp. appeals its loss in a patent infringement suit against the generics maker.

The appeals court had ordered a temporary injunction while it accepted briefing on Novartis’ likelihood of winning its appeal on the merits and the harm it would suffer if MSN was allowed to begin sales, among other factors.

“Based on the papers submitted, and without prejudicing the ultimate disposition of this case by a merits panel, we conclude that Novartis has not demonstrated entitlement to ...